Article Top Ad
Reading Time: 2 minutes

NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it is
investigating potential securities claims on behalf of shareholders of
Natus Medical, Inc. (NASDAQ:BABY) resulting from allegations that Natus
may have issued materially misleading business information to the
investing public.

On February 6, 2019, GlassHouse Research published a report entitled
“Throw the BABY (Natus Medical Inc.) Out with the Bathwater,” accusing
Natus of deceptive accounting practices. On this news, Natus’ share
price fell by more than 4%, closing at $31.50 on February 6, 2019.

Then, on May 6, 2019, after the market closed, Natus announced that it
would restate its previously announced financial results for the three
months ended March 31, 2019 when “the Company identified non-cash
currency translation adjustments and related tax effects that should
have been accounted for in connection with the impairment charge for the
divestiture of Medix.” On this news, shares of Natus fell after hours.

Rosen Law Firm is preparing a class action lawsuit to recover losses
suffered by Natus investors. If you purchased shares of Natus please
visit the firm’s website at
to join the class action. You may also contact Phillip Kim of Rosen Law
Firm toll free at 866-767-3653 or via email at [email protected]
or [email protected].

Follow us for updates on LinkedIn:
or on Twitter:
or on Facebook:

Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since 2013. Rosen
Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.


Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
Madison Avenue, 34th Floor
New York, NY 10016
(212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]